PRICE T ROWE ASSOCIATES INC 13D and 13G filings for IGM Biosciences, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2025-02-14 09:44 am Purchase |
2024-12-31 | 13G | IGM Biosciences, Inc. IGMS |
PRICE T ROWE ASSOCIATES INC | 3,568,999 10.500% |
3,503,059 (+5312.49%) |
Filing |
| 2025-02-07 11:55 am Sale |
2025-01-31 | 13G | IGM Biosciences, Inc. IGMS |
PRICE T ROWE ASSOCIATES INC | 65,940 0.200% |
-3,948,319 (-98.36%) |
Filing |
| 2024-11-14 1:22 pm Purchase |
2024-09-30 | 13G | IGM Biosciences, Inc. IGMS |
PRICE T ROWE ASSOCIATES INC | 4,014,259 11.800% |
610,545 (+17.94%) |
Filing |
| 2024-02-12 10:07 am Purchase |
2024-01-31 | 13G | IGM Biosciences, Inc. IGMS |
PRICE T ROWE ASSOCIATES INC | 3,403,714 10.300% |
141,505 (+4.34%) |
Filing |
| 2024-02-12 10:03 am Purchase |
2023-12-31 | 13G | IGM Biosciences, Inc. IGMS |
PRICE T ROWE ASSOCIATES INC | 3,262,209 9.900% |
1,055,802 (+47.85%) |
Filing |
| 2023-02-14 12:38 pm Sale |
2022-12-31 | 13G | IGM Biosciences, Inc. IGMS |
PRICE T ROWE ASSOCIATES INC | 2,206,407 7.600% |
-164,868 (-6.95%) |
Filing |
| 2022-02-14 2:34 pm Purchase |
2021-12-31 | 13G | IGM Biosciences, Inc. IGMS |
PRICE T ROWE ASSOCIATES INC | 2,371,275 9.100% |
1,042,491 (+78.45%) |
Filing |
| 2021-02-16 12:24 pm Purchase |
2020-12-31 | 13G | IGM Biosciences, Inc. IGMS |
PRICE T ROWE ASSOCIATES INC | 1,328,784 5.200% |
1,328,784 (New Position) |
Filing |